MYLK Knockout HAP1 Cell Line
Cat.No.:
EDC07982
Species:
Human
Cell Name:
HAP1
Gene:
MYLK
Gene ID:
4638
Size:
1×10⁶cells
MYLK Knockout HAP1 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07982 |
|---|---|
| Product Name | MYLK Knockout HAP1 Cell Line |
| Species | Human |
| Cell Line | HAP1 |
| Cellosaurus ID | CVCL_0F62 |
| Cell Line Synonyms | Highly Aggressively Proliferating Immortalized |
| Gene ID | |
| Gene | MYLK |
| Summary |
This gene, a muscle member of the immunoglobulin gene superfamily, encodes myosin light chain kinase which is a calcium/calmodulin dependent enzyme. This kinase phosphorylates myosin regulatory light chains to facilitate myosin interaction with actin filaments to produce contractile activity. This gene encodes both smooth muscle and nonmuscle isoforms. In addition, using a separate promoter in an intron in the 3' region, it encodes telokin, a small protein identical in sequence to the C-terminus of myosin light chain kinase, that is independently expressed in smooth muscle and functions to stabilize unphosphorylated myosin filaments. A pseudogene is located on the p arm of chromosome 3. Four transcript variants that produce four isoforms of the calcium/calmodulin dependent enzyme have been identified as well as two transcripts that produce two isoforms of telokin. Additional variants have been identified but lack full length transcripts. [provided by RefSeq, Jul 2008]
|
| Digestion Time | 2 min |
| Morphology | Adherent |
| Passage Ratio | 1:8~1:10 |
| Complete Culture Medium | IMDM+10%FBS |
| Freezing Medium | 90%FBS+10%DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
FAQ
Which is better for studying MYLK function, MYLK Knockout HAP1 Cell Line or MYLK overexpression HAP1 Cell Line?
The choice depends on whether you are studying MYLK (myosin light chain kinase, smooth muscle MLCK)'s role as a calcium/calmodulin-activated kinase or modeling its associations with thoracic aortic dissection susceptibility. The Knockout line is the standard tool for asking whether MYLK is required for these processes — MYLK is a multi-functional gene encoding multiple protein isoforms (smooth muscle MLCK, non-muscle MLCK, telokin) through alternative promoters and splicing, phosphorylating myosin regulatory light chain (MLC) to drive smooth muscle and non-muscle contractility. Overexpression is useful for studying MYLK in heterologous expression contexts.
For smooth muscle and vascular biology research, the EDITGENE MYLK Knockout in HAP1 enables study of MLCK biology — though physiological smooth muscle contractility requires smooth muscle cell models. Heterozygous MYLK loss-of-function mutations cause familial thoracic aortic aneurysm and dissection (FTAAD) — disease variant rescue enables genotype-function studies. Rescue with wild-type or kinase-dead MYLK enables comprehensive structure-function studies. The knockout is a critical specificity control for MLCK inhibitors (ML-7, ML-9) in cardiovascular research.
What are the application scenarios for this model?
Primary applications:
• MLC phosphorylation: phospho-MLC (S19) Western blot to assess MYLK kinase activity following calcium stimulation.
• Heterologous contractile studies: in heterologous smooth muscle or non-muscle cell contexts, characterization of MYLK-dependent contractility.
• FTAAD modeling: rescue with patient-derived MYLK mutations for genotype-function studies of familial thoracic aortic disease.
• MLCK inhibitor specificity: critical genetic control for ML-7, ML-9, and other MLCK inhibitors.
EDITGENE recommends this model for researchers investigating MYLK biology and FTAAD mechanisms; physiological smooth muscle contractility requires smooth muscle models.
Is this MYLK Knockout HAP1 Cell Line compatible with overexpression rescue experiments?
Yes. MYLK rescue experiments require attention to isoform diversity:
• Construct design: MYLK encodes multiple protein isoforms — choose the isoform appropriate to the experimental question (smooth muscle MLCK, non-muscle MLCK, telokin). Use codon-modified sequence with a small C-terminal tag (FLAG, HA).
• Kinase-dead rescue: ATP-binding lysine mutation abolishes catalytic activity and serves as the standard specificity control.
• Calmodulin-binding-deficient rescue: CaM-binding domain mutations enable separating Ca²⁺/CaM-dependent activation from intrinsic activity.
• FTAAD mutation rescue: patient-derived MYLK mutations enable disease genotype-function studies.
• Functional readout: rescue should restore MLC phosphorylation and contractile/mechanical responses.
HAP1-specific considerations:
• Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay.
• Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended.
• Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download